It serves pharmaceutical, biotech, and medical device companies, enabling them to streamline clinical trials and bring new therapies to market more quickly. Clario leverages advanced analytics, wearable technology, and global operational expertise to support trials in over 120 countries. The platform has...
The two medicines are in Phase 2 clinical trials. Inosine: A nutritional supplement that increases antioxidant levels. Some studies show it may have a protective effect or slow the progression of Parkinson's disease. Inosine is currently in a Phase 3 clinical trial. Isradipine: This medicine, ...
Seniors Set Sights High in Upcoming Mock TrialsLeo Fitzmaurice Of the Post-Dispatch
research and development programs; Mesoblast’s ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; Mesoblast’s ability to advance its manufacturing capabilities; the timing or likelihood of regulatory filings a...
the economy and the capital markets remain fixated on how policy changes will impact investor sentiment. With the biotech market trying to emerge from one of the worst downturns in biotech history, strong headwinds remain, and generalists remain on the sidelines for high-beta sectors like biotech....
Muhamed Baljevic, MD, FACP and Jorge Cortes, MD, discuss upcoming studies and emerging data being presented at the 2024 ASH Annual Meeting.
more narrowly focused anti-VEGF therapies. Suprachoroidal injection of this proprietary suspension of axitinib has demonstrated meaningful potential in Phase 1/2a and Phase 2b wet AMD clinical trials in which CLS-AX was well tolerated and demonstrated a positive safety profile. With s...
Kura Oncology's CEO, Troy Wilson, is slated to participate in three high-profile investor conferences, potentially increasing visibility and interest in the company's ongoing clinical developments. The company’s investigational therapy, ziftomenib, has received Breakthrough Therapy Designation from...
Dogs Legion's creative director Clint Hocking. While it's thought to be in early development, an early tease suggests a far darker setting that could revolve around Europe's bloody 16th century witch trials. Sadly, there's a good chance we'll be waiting until 2025 and beyond for this one...
READ MORE ON TESLA AUTONOMY:Tesla employees are performing autonomous FSD trials, CEO Elon Musk says Tesla announced in January that its vehicles at the factory in Fremont, California were driving themselves to the outbound lot, though this appears to be the first time they’ve done so at Giga...